Antimicrobial activity from the extracts of fungal isolates of soil and dung samples from Kaziranga National Park, Assam, India;Activité antimicrobienne d'extraits d'isolats fongiques du sol et du fumier du parc national de Kaziranga, Assam, Inde

Journal de Mycologie Medicale

Volumn 20, Issue 4, 2010, Pages 283-289

  Ganesh Kumar, C ^a   Mongolla, P ^a   Joseph, J ^a   Nageswar, Y V D ^a   Kamal, A ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antimicrobial activity; Fungi; Kaziranga National Park; Secondary metabolites

Indexed keywords

FUNGAL EXTRACT;

ACREMONIUM; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS; AUREOBASIDIUM PULLULANS; BACILLUS SUBTILIS; CANDIDA; CANDIDA ALBICANS; CURVULARIA; DRUG POTENCY; ESCHERICHIA COLI; FUNGAL STRAIN; FUNGUS ISOLATION; FUSARIUM; GENUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INDIA; KLEBSIELLA; MICROCOCCUS LUTEUS; NATIONAL PARK; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCOPULARIOPSIS; SOIL MICROFLORA; STAPHYLOCOCCUS AUREUS;

ACREMONIUM (ASCOMYCOTA); ASPERGILLUS; AUREOBASIDIUM PULLULANS; BACTERIA (MICROORGANISMS); BOTRYOSPHAERIA RHODINA; CANDIDA; CURVULARIA; FUNGI; FUSARIUM; NEGIBACTERIA; PHOMA; POSIBACTERIA; SCOPULARIOPSIS;

EID: 78649972050     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2010.08.002     Document Type: Article

References (35)

1. Bugni T.S., Abbanat D., Bernan V.S., Maiese W.M., Greenstein M., Wagoner R.M.V., et al. Yanuthones: novel metabolites from a marine isolate of Aspergillus niger. J Org Chem 2000, 65:7195-7200.
2. Basic biotechnology 1997, 433. Academic Press, New York. J.D. Bulock, B. Kristiansen (Eds.).
3. Chan S. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 2004, 91:1420-1424.
4. Clardy J., Fischbach M.A., Walsh C.T. New antibiotics from bacterial natural products. Nature Biotechnol 2006, 24:1541-1550.
5. Dreyfuss M.M., Chapela I.H. Potential of fungi in the discovery of novel, low molecular weight pharmaceuticals. The discovery of natural products with therapeutic potential 1994, 49-80. Butterworth-Heinemann, Boston. V.P. Gullo (Ed.).
6. Ehrlich J., Bartz Q.R., Smith R.M., Josyln D.A., Burkholder P.R. Chloramphenicol, a new antibiotic from soil actinomycetes. Science 1947, 106:417.
7. Fiedler H.P., Bruntner C., Bull A.T., Ward A.C., Goodfellow M., Potterat O., et al. Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek 2004, 87:37-42.
8. Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929, 10:226-236.
9. Ganellin C.R., Roberts S.M. General approaches to discovering new drugs: a historical perspective. Medicinal chemistry. 2nd, Chapter 7 1993, Academic Press, San Diego.
10. Glover J.B. Applications of fungal ecology in the search of new bioactive natural products. The Mycota IV: environmental, microbial relationships 1995, 249-268. Springer-Verlag, Berlin Heidelberg. D.T. Wicklow, B.E. Söderström (Eds.).
11. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
12. Höller U., Wright A.D., Matthee G.F., Konig G.M., Draeger S., Aust H.J., et al. Fungi from marine sponges: diversity, biological activity and secondary metabolites. Mycol Res 2000, 104:1354-1365.
13. Hyde K.D. Increasing the likelihood of novel compound discovery from filamentous fungi. Bio-exploitation of filamentous fungi, fungal diversity research, Series 6 2001, 77-91. Fungal Diversity Press, Hong Kong. S.B. Pointing, K.D. Hyde (Eds.).
14. Kumar C.G., Himabindu M., Jetty A. Microbial biosynthesis and applications of gentamicin: a critical appraisal. Crit Rev Biotechnol 2008, 28:173-212.
15. Kutzner K.J. The family Streptomycetaceae. The Prokaryotes: a handbook on habitats, isolation and identification of bacteria 1986, vol 2:202-2090. Springer Verlag, New York.
16. Lin Y., Wu X., Feng S., Jiang G., Luo J., Zhou S., et al. Five unique compounds: xyloketales from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem 2001, 66:6252-6256.
17. McGuire J.M., Bunch R.L., Anderson R.C., Boaz H.E., Flynn E.H., Powell H.M., et al. Ilotycin, a new antibiotic. Antibiot Chemother 1952, 2:281-283.
18. Nedialkova D., Naidenova M. Screening the antimicrobial activity of actinomycetes strains isolated from Antarctica. J Culture Collections 2004-2005, 4:29-35.
19. Okazaki T., Naito A. Studies on actinomycetes isolated from Australian soil. Biological, biochemical and biomedical aspects of actinomycetes 1986, 739-741. Akademiai Kiado, Budapest. G. Szabo, S. Biro, M. Goodfellow (Eds.).
20. Phoebe, CHJr, Combie J., Alert F.G., Van Tran K., Cabrera J., et al. Extremophilic organisms as an unexplored source of antifungal compounds. J Antibiot 2001, 54:56-65.
21. Saadoun I., Gharaibeh R. The Streptomyces flora of Badia region of Jordan and its potential as a source of antibiotic-resistant bacteria. J Arid Environ 2003, 53:365-371.
22. Sanglier J.J., Haag H., Huck T.A., Fehr T. Review of actinomycetes compounds: 1990-1995. Expert Opin Invest Drugs 1996, 5:207-223.
23. Schatz A., Bugie E., Waksman S.A., Streptomycin a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc Soc Exp Biol Med 1944, 55:66-69.
24. Scherrer R., Gerhardt P. Molecular sieving by the Bacillus megaterium cell wall and protoplast. J Bacteriol 1971, 107:718-735.
25. Schulz B., Boyle C., Draeger S., Römmert A.-K., Krohn K. Endophytic fungi: a source of novel biologically active secondary metabolites. Mycol Res 2002, 106:996-1004.
26. Sengupta R., Chandran R.R., Divekar P.V., Botryodiplodin a new antibiotic from Botryodiplodia theobromae. I. Production, isolation, and biological properties. Indian J Exp Biol 1966, 4:152-153.
27. Shu Y.Z. Recent natural products based drug development: a pharmaceutical industry perspective. J Nat Products 1998, 61:1053-1071.
28. Strobel G.A. Microbial gifts from rain forests. Can J Plant Pathol 2000, 24:14-20.
29. Suryanarayanan T.S., Thirunavukkarasu N., Govindarajulu M.B., Sasse F., Jansen R., Murali T.S. Fungal endophytes and bioprospecting. Fungal Biol Rev (England) 2009, 23:9-19.
30. Takesako K., Ikai K., Haruna F., Endo M., Shimanaka K., Sona K., et al. Aureobasidins, new antifungal antibiotics, taxonomy, fermentation, isolation and properties. J Antibiot (Tokyo) 1993, 44:919-924.
31. UNESCO. State of conservation of world heritage properties in the Asia-Pacific region - Kaziranga national park, UNESCO; 2010 [. (Retrieved on 08 May 2010)]. http://whc.unesco.org/archive/periodicreporting/APA/cycle01/section2/337 -summary.pdf.
32. Varma G.B., Fatope M.O., Marwah R.G., Deadman M.E., Al-Rawahi F.K. Production of phenylacetic acid derivatives and 4-epiradicinol in culture by Curvularia lunata. Phytochemistry 2006, 67:1925-1930.
33. Vézina C., Kudelski A., Sehgal S.N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 1975, 28:721-726.
34. Waksman S.A. Classification, identification and description of genera and species. The Actinomycetes, 1961, vol. 2:1-363. Williams and Wilkins, Baltimore, MD.
35. Weinstein M.J., Luedemann G.M., Oden E.M., Wagman G.H., Rosselet J.P., Marquez J.A., et al. Gentamicin, new antibiotic complex from Micromonospora. J Med Chem 1963, 6:463-464.